Clumax Diagnostic And Research Centre Profile
Key Indicators
- Authorised Capital ₹ 1.67 Cr
- Paid Up Capital ₹ 1.00 Cr
- Company Age 20 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 201.90 Cr
- Satisfied Charges ₹ 318.83 Cr
- Revenue Growth 25.70%
- Profit Growth 81.39%
- Ebitda 128.54%
- Net Worth -15.15%
- Total Assets -8.19%
About Clumax Diagnostic And Research Centre
Clumax Diagnostic And Research Centre Private Limited (CDARCPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 24 November 2004 and has a history of 20 years and three months. Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.67 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹201.90 Cr. The company has closed loans amounting to ₹318.83 Cr, as per Ministry of Corporate Affairs (MCA) records.
Yogeshwaran Nagarajan and Ravi Aggarwal serve as directors at the Company.
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
- Apps
Corporate Identity Details
- CIN/LLPIN
U85110KA2004PTC035092
- Company No.
035092
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Nov 2004
- Date of AGM
07 May 2024
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Clumax Diagnostic And Research Centre?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Yogeshwaran Nagarajan  | Director | 05-Dec-2022 | Current |
| Ravi Aggarwal | Director | 05-Dec-2022 | Current |
Financial Performance of Clumax Diagnostic And Research Centre.
Clumax Diagnostic And Research Centre Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 25.7% increase. The company also saw a substantial improvement in profitability, with a 81.39% increase in profit. The company's net worth observed a substantial decline by a decrease of 15.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Clumax Diagnostic And Research Centre?
In 2022, Clumax Diagnostic And Research Centre had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Medall Spark Diagnostics Nashik Private LimitedYogeshwaran Nagarajan and Ravi Aggarwal are mutual person
- Medall Scans And Labs Marthahalli Private Limited
Yogeshwaran Nagarajan and Ravi Aggarwal are mutual person
- Medall Scans And Labs Ranchi Private Limited
Yogeshwaran Nagarajan and Ravi Aggarwal are mutual person
- Medall Visakhapatnam Private Limited
Yogeshwaran Nagarajan and Ravi Aggarwal are mutual person
Charges (Loans)
₹201.90 Cr
₹318.83 Cr
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 105.50 Cr
- Others : 96.40 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Feb 2021 | Others | ₹4.20 Cr | Open |
| 23 Apr 2019 | Others | ₹92.20 Cr | Open |
| 28 Jan 2019 | Axis Bank Limited | ₹105.50 Cr | Open |
| 13 May 2020 | The Catholic Syrian Bank Ltd | ₹10.00 Cr | Satisfied |
| 21 Aug 2017 | Hdfc Bank Limited | ₹170.28 Cr | Satisfied |
How Many Employees Work at Clumax Diagnostic And Research Centre?
Unlock and access historical data on people associated with Clumax Diagnostic And Research Centre, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Clumax Diagnostic And Research Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Clumax Diagnostic And Research Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
